Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database

by Stephanie H. Greco, MD, David A. August, MD, Mihir M. Shah, MD, Chunxia Chen, MS, Dirk F. Moore, PhD, Monika Masanam, BA, Amber L. Turner, MPH, Salma K. Jabbour, MD, Parisa Javidian, MD, Miral S. Grandhi, MD, Timothy J. Kennedy, MD, H. Richard Alexander, MD, Darren R. Carpizo, MD, PhD, Russell C. Langan, MD
Published 2021-01-01